Literature DB >> 8977135

The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.

L Ferraro1, S Tanganelli, W T O'Connor, T Antonelli, F Rambert, K Fuxe.   

Abstract

The effect of modafinil on endogenous gamma-aminobutyric acid (GABA) release in the medial preoptic area (MPA) and posterior hypothalamus (PH) and the role of local 5-HT3 receptors in this effect was investigated in the awake rat using in vivo microdialysis. Modafinil (30-100 mg/kg i.p.) dose-dependently decreased GABA release from the MPA, while only the 100 mg/kg dose markedly reduced GABA release in the PH. The modafinil (100 mg/kg) induced inhibition of GABA release in the MPA and the PH was partially counteracted by the 5-HT3 receptor antagonist MDL72222 (1 microM) when perfused locally alone or together with the non-selective 5-HT receptor antagonist methysergide (1 microM). Thus, the reduction of GABA transmission induced by modafinil in the MPA and in the PH, at least in part, involves local 5-HT3 receptors. The GABA release inhibition by modafinil in the above areas may be relevant for its vigilance promoting action.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977135     DOI: 10.1016/s0304-3940(96)13212-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

1.  Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison.

Authors:  N Rycroft; S B Hutton; O Clowry; C Groomsbridge; A Sierakowski; J M Rusted
Journal:  Psychopharmacology (Berl)       Date:  2007-08-05       Impact factor: 4.530

Review 2.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

Review 3.  Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment.

Authors:  E S Vizi; A Fekete; R Karoly; A Mike
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

4.  Transitions between sleep and feeding states in rat ventral striatum neurons.

Authors:  Luis A Tellez; Isaac O Perez; Sidney A Simon; Ranier Gutierrez
Journal:  J Neurophysiol       Date:  2012-06-27       Impact factor: 2.714

Review 5.  Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.

Authors:  Gillian M Keating; Michael J Raffin
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

6.  Modafinil : A Review of its Pharmacology and Clinical Efficacy in the Management of Narcolepsy.

Authors:  K J McClellan; C M Spencer
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

Review 7.  Adjunctive use of modafinil in bipolar patients: just another stimulant or not?

Authors:  Richard C Shelton; Rakesh Reddy
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

8.  Impact of Astroglial Connexins on Modafinil Pharmacological Properties.

Authors:  Adeline Duchêne; Magali Perier; Yan Zhao; Xinhe Liu; Julien Thomasson; Frédéric Chauveau; Christophe Piérard; Didier Lagarde; Christèle Picoli; Tiffany Jeanson; Franck Mouthon; Yves Dauvilliers; Christian Giaume; Jian-Sheng Lin; Mathieu Charvériat
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

9.  Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG.

Authors:  Florian Chapotot; Ross Pigeau; Frédéric Canini; Lionel Bourdon; Alain Buguet
Journal:  Psychopharmacology (Berl)       Date:  2003-01-28       Impact factor: 4.530

10.  Effect of modafinil on cerebral blood flow in narcolepsy patients.

Authors:  Eun Yeon Joo; Dae Won Seo; Woo Suk Tae; Seung Bong Hong
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.